[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340195-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340195-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","paip1-binds-to-pre-mrna-and-regulates-alternative-splicing-of-cancer-pathway-genes-including-vegfa","PAIP1 binds to pre-mRNA and regulates alternative splicing of cancer pathway genes including VEGFA","","Poly(A) binding protein interacting protein 1 (PAIP1) contributes to cancer development, but how PAIP1 regulates tumor-cell RNA processes remains unclear. This study maps PAIP1 direct and indirect RNA interaction sites across the transcriptome in HeLa cells using UV cross-linking and iRIP-seq. Results show preferential PAIP1 binding to coding regions and introns enriched for GA-rich splicing enhancer motifs, selective modulation of cancer-hallmark splicing events, and functional dependence on a VEGFA exon 6 regulatory binding site with GA repeats. Proteomics link PAIP1-interacting partners to spliceosome components and splicing factors. Findings support PAIP1 as a regulator of both polyadenylation and alternative splicing in RNA processing.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/paip1-binds-to-pre-mrna-and-regulates-alternative-splicing-of-cancer-pathway-genes-including-vegfa/340195/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/paip1-binds-to-pre-mrna-and-regulates-alternative-splicing-of-cancer-pathway-genes-including-vegfa/340195.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main biological problem addressed by this study?","Question",{"text":63,"@type":64},"How PAIP1 regulates tumor-cell RNA processing is not well understood, including its control of alternative splicing related to cancer genes such as VEGFA.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the authors map PAIP1-RNA interactions in cells?",{"text":68,"@type":64},"They used a UV cross-linking and RNA immunoprecipitation method (iRIP-seq) to identify PAIP1 interaction sites transcriptome-wide in HeLa cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence connects PAIP1 binding to alternative splicing changes and VEGFA isoforms?",{"text":72,"@type":64},"PAIP1 binding sites correlate with alternative splicing events across cancer hallmark pathways, and deleting a PAIP1 binding site containing seven GA motif repeats reduced PAIP1-mediated suppression of exon 6 inclusion in a VEGFA mRNA isoform.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340195,1790149593,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Zheng et al. BMC Genomics (2024) 25:926 BMC Genomics  \n[https://doi.org/10.1186/s12864-024-10530-9](https://doi.org/10.1186/s12864-024-10530-9)  \nRESEARCH Open Access  \nPAIP1 binds to pre-mRNA and regulates  alternative splicing of cancer pathway genes including VEGFA  \nJianfeng Zheng 1,2, Xiaoyu Zhang3, Yaqiang Xue4,5, Wenhua Shao2, Yaxun Wei4, Sisi Mi2, Xiaojie Yang2, Linan Hu6, Yi Zhang4,5* and Ming Liang3*  \nAbstract  \nBackground Poly (A) binding protein interacting protein 1 (PAIP1) has been shown to causally contribute to the development and progression of cancer. However, the mechanisms ofthe PAIP1 regulation in tumor cells remain poorly understood.  \nResults Here, we used a recently developed UV cross-linking and RNA immunoprecipitation method (iRIP-seq) to map the direct and indirect interaction sites between PAIP1 and RNA on a transcriptome-wide level in HeLa cells. We found that PAIP1 not only binds to 3’UTRs, but also to pre-mRNAs/mRNAs with a strong bias towards the coding region and intron. PAIP1 binding sites are enriched in splicing enhancer consensus GA-rich motifs. RNA-seq analysis revealed that PAIP1 selectively modulates the alternative splicing of genes in some cancer hallmarks including cell migration, the mTOR signaling pathway and the HIF-1 signaling pathway. PAIP1-regulated alternative splicing events were strongly associated with PAIP1 binding, demonstrating that the binding may promote selection of the nearby splice sites. Deletion of a PAIP1 binding site containing seven repeats of GA motif reduced the PAIP1-mediated suppression of the exon 6 inclusion in a VEGFA mRNA isoform. Proteomic analysis of the PAIP1-interacted proteins revealed the enrichment of the spliceosome components and splicing factors.  \nConclusions These findings suggest that PAIP1 is both a polyadenylation and alternative splicing regulator, that may play a large role in RNA processing via its role in alternative splicing regulation.  \nKeywords RNA binding protein, PAIP1, Alternative splicing, VEGFA, RNA immunoprecipitation  \n*Correspondence: Yi Zhang [yizhang@ablife.cc](yizhang@ablife.cc)[ ](yizhang@ablife.cc)Ming Liang [lm19780816@126.com](lm19780816@126.com)  \n1Department of Laboratory Medicine, Baoan Central Hospital of Shenzhen, Shenzhen 518102, Guangdong, P. R. China  \n2Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin 541004, Guangxi, China  \n3First department of infection, second affiliated hospital of Harbin medical university, 246 Xuefu Road, Harbin 150000, Heilongjiang, China 4Center for Genome Analysis, ABLife Inc, Optics Valley International Biomedical Park, Building 18-1, East Lake High-Tech Development Zone, Wuhan 430075, Hubei, China  \n5ABLife BioBigData Institute, 388 Gaoxin 2nd Road, Wuhan 430075, Hubei, China  \n6Harbin Center for Disease Prevention and Control, Harbin 150056, Heilongjiang, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.org/l](creativecommons.org/l)icenses/by-nc-nd","cbCaiuIcG4jhM41H","https://ap.wps.com/l/cbCaiuIcG4jhM41H","pdf",8347921,15,"English","# Abstract\n## Background\n## Results\n## Conclusions\n# Introduction\n## mRNA life cycle and RNA-binding proteins\n## Polyadenylation and alternative polyadenylation\n## Links between splicing factors and alternative polyadenylation","[{\"question\":\"What is the main biological problem addressed by this study?\",\"answer\":\"How PAIP1 regulates tumor-cell RNA processing is not well understood, including its control of alternative splicing related to cancer genes such as VEGFA.\"},{\"question\":\"How did the authors map PAIP1-RNA interactions in cells?\",\"answer\":\"They used a UV cross-linking and RNA immunoprecipitation method (iRIP-seq) to identify PAIP1 interaction sites transcriptome-wide in HeLa cells.\"},{\"question\":\"What evidence connects PAIP1 binding to alternative splicing changes and VEGFA isoforms?\",\"answer\":\"PAIP1 binding sites correlate with alternative splicing events across cancer hallmark pathways, and deleting a PAIP1 binding site containing seven GA motif repeats reduced PAIP1-mediated suppression of exon 6 inclusion in a VEGFA mRNA isoform.\"}]","PAIP1 binds to pre-mRNA and regulates alternative splicing of cancer pathway genes including VEGFA | PDF",1790034874,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56f39b793882067874f7c1743d722302.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d538739df15299376ee37a880e1e528.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9ad1e30a08023fb271ff9a99a464f5f.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f7fa0ed4ee73c880f9b8af71310ff0e.webp",980,1306]